Why GLP-1 Medications Work for Some Women with Lipedema and Not Others: Genetics, Metabolism & Anti-Inflammatory Nutrition”
Virtual Event
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and newer dual agonists such as tirzepatide are transforming obesity care, yet many women with lipedema experience highly variable results—from dramatic weight loss to almost no change at all. This webinar will explore why. Drawing on the recent study identifying neurobeachin (NBEA) as a novel gene associated with GLP-1–related
Members Only
